The International Politics of Vaccine Testing in Interwar Algiers

The Algiers BCG trial, conducted by Albert Calmette and his team at the Pasteur Institute between 1930 and 1934, was a groundbreaking effort to establish the efficacy of the tuberculosis (TB) vaccine BCG. It marked one of the first large-scale randomized clinical trials with a control group, setting a precedent for future medical research. The trial took place in the Kasbah neighborhood of Algiers, a densely populated and predominantly Muslim area that offered unique advantages: robust civil records and minimal resistance from local doctors or patients. Over 40,000 children were vaccinated, and their health was monitored over four years. While the trial ultimately failed to definitively prove BCG's efficacy due to methodological challenges—such as insufficient long-term follow-up and political interference—the study laid critical groundwork for modern clinical trial standards, including randomized designs and control groups. This research also highlighted the complex interplay between international scientific politics, colonial power dynamics, and public health in interwar Algiers.

Rosenberg, C. (2012). The International Politics of Vaccine Testing in Interwar Algiers. The American Historical Review, 117(3), 671–697. https://doi.org/10.1086/ahr.117.3.671